Wave Life Sciences: director Henry Christian O received 74,700 shares

What happened

• Henry Christian O, a director of Wave Life Sciences, was granted 10,700 restricted stock units (RSUs) and an option covering 64,000 shares on Oct 5, 2026. Both transactions are reported as awards/grants (transaction code A) at $0 per share.

Key details

• Transaction date: Oct 5, 2026; filing date: Oct 7, 2026.
• Price: $0.00 for both the 10,700 RSUs and the 64,000-share option.
• Shares acquired: 10,700 RSUs (acquired) and 64,000 derivative (option) = 74,700 total.
• Shares owned following the reported transaction: not stated in the filing.
• Vesting: both awards vest 100% on the earlier of the company's 2027 annual meeting of stockholders or Oct 5, 2027 (footnotes F1 and F2).
• Remarks in the filing note that on Aug 7, 2026, Wave Life Sciences, Inc. became the successor to Wave Life Sciences Ltd. pursuant to a scheme of arrangement (redomiciliation).
• Exhibit included: 24.1 power of attorney.

Why it may matter

• These were grant/award transactions, not open-market purchases or sales; the option is a derivative grant rather than an exercised option or a gift.
• This filing does not show why the insider traded or why the company acted.